P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
Heidi Mocikova,
Jana Markova,
Lubica Gaherova,
Maria Maco,
Alice Sýkorová,
David Belada,
Marie Lukášová,
Vit Prochazka,
Juraj Duras,
Tomas Kozak
Affiliations
Heidi Mocikova
1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic
Jana Markova
1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic
Lubica Gaherova
1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic
Maria Maco
1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic
Alice Sýkorová
2 University Hospital and Faculty of Medicine, 4th Department of Internal Medicine– Hematology, Hradec Kralove, Czech Republic
David Belada
2 University Hospital and Faculty of Medicine, 4th Department of Internal Medicine– Hematology, Hradec Kralove, Czech Republic
Marie Lukášová
3 Faculty of Medicine and Dentistry, Palacky University, Department of Haemato-Oncology, Olomouc, Czech Republic
Vit Prochazka
3 Faculty of Medicine and Dentistry, Palacky University, Department of Haemato-Oncology, Olomouc, Czech Republic
Juraj Duras
4 University Hospital and Faculty of Medicine, Department of Hemato-Oncology, Ostrava, Czech Republic
Tomas Kozak
1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic
